1. These results provide support for researchers' prediction that naltrexone will turn out to be toxic to certain types of bacteria.
这些结果支持了研究人员的预测，即纳曲酮对某些类型的细菌是有害的。
youdao
2. When mice are given both morphine and the new drug naltrexone, blood poisoning is much less frequent, although it does still occur.
当老鼠同时服用吗啡和新型药物纳曲酮时，虽然仍会发生血液中毒，但发生的频率大大降低。
youdao
3. So, the role of naltrexone improving memory is also required further study.
对纳曲酮改善记忆的作用还需要做进一步的研究。
youdao
4. Invitro release of naltrexone microspheres prepared with the various PLGA were compared.
以其为载体制备纳曲酮微球，比较了体外释药速率。
youdao
5. Low dose naltrexone combined with cisplatin, but not taxol, had an additive inhibitory action on tumorigenesis.
低剂量的纳曲酮结合顺铂的治疗方式，有更好的肿瘤抑制作用。
youdao
6. Bupropion and naltrexone are both widely regarded as having a fairly good profile with regard to risks and side effects.
安非他酮和纳曲酮都被广泛视为具有相当好的姿态方面的风险和副作用。
youdao
7. The FDA is requiring that a medication guide about treatment with naltrexone extended-release injectable suspension be provided to all patients.
FDA正在要求制订一份可提供给所有患者的有关使用纳曲酮缓释注射用混悬剂治疗的用药指南。
youdao
8. Naltrexone extended-release injectable suspension is the first — and currently the only — once-monthly injectable medication for alcohol dependence.
纳曲酮缓释注射用混悬剂是首个也是目前仅有的每月注射一次用于治疗酒精依赖的药物。
youdao
9. Therefore low dose naltrexone offers a non-toxic and efficacious biologic pathway-related treatment that may benefit patients with this ovarian cancer.
因此，低剂量纳曲酮提供了一种无毒的和有效的生物途径疗法，可能对卵巢癌患者有所助益”。
youdao
10. Queensland heroin users will be able to detoxify rapidly on Naltrexone after a two-year clinical trial of the controversial drug begins in Brisbane this week.
11. Naltrexone (NTX) is a general opioid receptor antagonist devoid of intrinsic activity that results in a compensatory elevation in endogenous opioids and opioid receptors.
12. Results showed that morepatients in the sertraline plus naltrexone group (53.7 percent) were abstinentfor the 14 weeks of treatment than the patients in the other groups combined.
13. Results showed that morepatients in the sertraline plus naltrexone group (53.7 percent) were abstinentfor the 14 weeks of treatment than the patients in the other groups combined.
